Brain Scientific Inc.
BRSF
$0.00
-$0.75-99.99%
OTC PK
| 12/31/2022 | 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | |
|---|---|---|---|---|---|
| Revenue | 5.10K | 11.40K | 38.50K | 159.60K | 251.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 5.10K | 11.40K | 38.50K | 159.60K | 251.30K |
| Cost of Revenue | 11.50K | 4.10K | 38.00K | 106.70K | 174.70K |
| Gross Profit | -6.50K | 7.40K | 500.00 | 52.90K | 76.60K |
| SG&A Expenses | 1.42M | 3.97M | 2.11M | 1.86M | 5.05M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.51M | 4.03M | 2.23M | 2.05M | 5.40M |
| Operating Income | -1.50M | -4.02M | -2.19M | -1.89M | -5.15M |
| Income Before Tax | -3.23M | -4.44M | -2.51M | -2.16M | -5.53M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.23M | -4.44M | -2.51M | -2.16M | -5.53M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.23M | -4.44M | -2.51M | -2.16M | -5.53M |
| EBIT | -1.50M | -4.02M | -2.19M | -1.89M | -5.15M |
| EBITDA | -1.28M | -3.82M | -1.99M | -1.69M | -4.95M |
| EPS Basic | -2.58 | -3.58 | -3.50 | -3.63 | -13.41 |
| Normalized Basic EPS | -1.26 | -2.24 | -2.19 | -2.27 | -8.38 |
| EPS Diluted | -2.58 | -3.58 | -3.50 | -3.63 | -13.41 |
| Normalized Diluted EPS | -1.26 | -2.24 | -2.19 | -2.27 | -8.38 |
| Average Basic Shares Outstanding | 1.25M | 1.24M | 718.90K | 594.80K | 412.10K |
| Average Diluted Shares Outstanding | 1.25M | 1.24M | 718.90K | 594.80K | 412.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |